Definitive Contract HHSO100201500021C
Award Date
9/28/15
Potential Completion Date
9/30/27
Potential Value
$39M
Awardee
Polynovo Biomaterials PTY LTD
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Australia
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Porton Biopharma Limited, a foreign-owned for-profit organization, with a ceiling value of $12,323,733.00. The contract was awarded as a result of a novation, with the prior contract HHSN272201200032C with Public Health England now being HHSN272201600045C with Porton Biopharma Limited as the successor-in-interest contractor. The contract does not...
This is a $65,806,649.98 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Biofactura Inc., a for-profit manufacturer located in Frederick, Maryland. The contract includes preclinical and manufacturing development activities such as cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract has an...
This is a $93,164,303.39 cost plus fixed fee definitive contract awarded by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization, on September 14, 2015. The contract has an ultimate completion date of August 16, 2024 and is not set-aside. The contract is for products and services related to HHS's preparedness and response programs, though...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Vaxine PTY LTD, a for-profit organization located in Australia. The $18,541,473.00 contract is for the "ADVANCED DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES". The contract has an end date of August 14, 2023 and was initially awarded on September 20, 2018. This contract...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
<p>This is a cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization. The $196,408,488.00 contract does not have a set-aside designation and has an ultimate completion date of March 30, 2026. The contract was awarded on September 28, 2017.</p>
This is a $115,034,515.00 Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Velico Medical, Inc. to advance the development of the FRONTLINEODP™ system for producing a point of care plasma product for transfusion. The contract has an ultimate completion date of December 31, 2025 and does not utilize a set-aside designation. No further details about subcontractors or larger contract vehicles were provided.
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This is a firm fixed-price purchase order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Flexbiosys Inc., a small business manufacturer of pharmaceutical consumables. The contract, valued at $14,372,753.00, is to expand and accelerate Flexbiosys' domestic production capacity for single-use bags, tubing, and associated components to support COVID-19 vaccine development...